Dáil Éireann Debate, Thursday - 14 May 2026
775. Deputy Ken O'Flynn asked the Minister for Health whether any review has been undertaken into the drivers of variation in average reimbursement cost per salbutamol nebule item under the General Medical Services scheme since 2024. [36450/26]
Amharc ar fhreagraUnder the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
